Renal hemodynamic changes associated with antidiuretic actions of chlorpropamide, clofibrate and thiazide in diabetes insipidus

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A careful study was performed in two patients of idiopathic diabetes insipidus (DI) to assess the role of renal hemodynamic changes in antidiuresis induced by several agents commonly used for the treatment of DI patients. In one patient, every one of chlorpropamide, clofibrate and thiazide caused a decrease in effective renal plasma flow (ERPF) by about 20% in association with a decrease in urine volume by 40-50%. No significant decrease in GFR was seen in the patient. In the other patient, every one of the above drugs caused a decrease not only in ERPF (by 25-40%) but also in GFR (by 25-35%) in association with a more remarkable decrease in urine volume (by 60-70%). These renal hemodynamic changes resembled those induced by the administration of exogenous vasopressin. Thus renal hemodynamic changes should be taken into consideration when one studies the mechanism of antidiuresis induced by the drugs mentioned above. © 1973, The Japanese Circulation Society. All rights reserved.

Cite

CITATION STYLE

APA

Wada, T., Kitamoto, K., Nomoto, Y., Yoshida, R., Yamauchi, M., Kato, E., & Asano, S. (1973). Renal hemodynamic changes associated with antidiuretic actions of chlorpropamide, clofibrate and thiazide in diabetes insipidus. JAPANESE CIRCULATION JOURNAL, 37(8), 935–939. https://doi.org/10.1253/jcj.37.935

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free